VISHEE(SH:688580) Shang Hai Zheng Quan Bao·2025-11-12 18:38Core Viewpoint - The announcement details the completion of a share reduction plan by a major shareholder of Weisi Medical, indicating the amount and method of shares sold, as well as the overall impact on the company's total share capital [1][3]. Summary by Sections Shareholder Reduction Overview - The shareholder, Nanjing Zhida Venture Capital Center (Limited Partnership), held 7,935,120 shares prior to the reduction, representing 8.29% of the total share capital of Weisi Medical [2]. Implementation Results of the Reduction Plan - The reduction plan was disclosed on July 23, 2025, with a timeframe set from August 14, 2025, to November 11, 2025. The shareholder planned to reduce up to 2,873,137 shares, which would account for a maximum of 3% of the total share capital. This included a maximum of 957,712 shares through centralized bidding (1% of total shares) and 1,915,425 shares through block trading (2% of total shares) [3]. - The actual reduction results showed that from August 14 to November 11, 2025, the shareholder reduced 956,052 shares through centralized bidding (0.9983% of total shares) and 220,730 shares through block trading (0.2305% of total shares), totaling 1,176,782 shares, which is 1.2287% of the total share capital [3][4]. Additional Information - The reduction plan was fully implemented as planned, with no early termination of the plan [4].